My Account
Log in Registration
All
Cart
Highlights
Fiction Books
Non-Fiction Books
Children's Books
Rare Books
Music
DVD & Blu-Ray
Video Games
Category
Wishlists
Cart
All
Free Shipping in Australia
Trustpilot
Proud to be B-Corp

Parkinsonian Disorders in Clinical Practice Anthony Schapira

Parkinsonian Disorders in Clinical Practice By Anthony Schapira

Parkinsonian Disorders in Clinical Practice by Anthony Schapira

Reviews:
$17.49
Condition - Very Good
Only 2 left
Very Good

Summary

This book gives the reader an up-to-date, clear and logical idea of what caring for parkinsonian patients entails - a challenge that clinicians will face for many years to come.

Parkinsonian Disorders in Clinical Practice Summary

Parkinsonian Disorders in Clinical Practice by Anthony Schapira

This book gives the reader an up-to-date, clear and logical idea of what caring for parkinsonian patients entails - a challenge that clinicians will face for many years to come. It is split into three sections:

Section 1: A compilation of the major brain lesions typically seen in PD

Section 2: Treatment options in PD

Section 3: 25 cases designed to test the reader and the practical application of the information supplied in the other sections.

About Anthony Schapira

Anthony HV Schapira, MD DSC, FRCP, FMedSci, Professor and Head of Department University College of Clinical Neurosciences, Institute of Neurology, University College London, Queen Square, London UK. Professor of Neurology, National Hospital for Neurology and Neurosurgery and Roayl Free Hospital, London, UK.

Andreas Hartmann, MD, Clinical Investigation Center, Pitie-Salpetriere Hopital, Paris, France. Federation of Nervous System Disease, Pitie-Salpetriere Hopital, Paris, France. National Institute of Health and Medical Research, Paris, France. Pierre and MAric Curie University,?Paris, France.

Yves Agid, MD, PhD, Clinical Investigation Center, Pitie-Salpetriere Hopital, Paris, France. Federation of Nervous System Disease, Pitie-Salpetriere Hopital, Paris, France. National Institute of Health and Medical Research, Paris, France. Pierre and MAric Curie University,?Paris, France.

Table of Contents

Preface.

Introduction.

1 What is Parkinson's disease? From pathophysiology to symptoms (Andreas Hartmann, Yves Agid, Anthony Schapira).

I. Pathophysiology of Parkinson's disease.

1. Dysfunctions of the main neuronal pathways in Parkinson's disease.

a. An overview of neuronal systems affected in Parkinson's disease.

b. Dopaminergic neurons.

c. Non-dopaminergic neurons.

2. Consequences of dopaminergic neuronal lesions on basal ganglia circuits.

a. The dopaminergic nigrostriatal system: pre- and postsynaptic compensatory mechanisms.

b. Pathologic alterations of nigrostriatal circuits in Parkinson's disease.

3. Histopathology of Parkinson's disease.

4. The etiopathogenesis of Parkinson's disease.

a. The genetics of Parkinson's disease: any clues for the sporadic forms?

b. Relevant environmental factors: focus on mitochondria.

c. Mechanisms of cell death in Parkinson's disease: therapeutic implications.

5. Conclusions.

a. Parkinson's disease or Parkinson's syndromes?

b. What Parkinson's disease is not.

II. Clinical features of Parkinson's disease.

1. Motor symptoms.

2. Non-motor symptoms.

a. Depression.

b. Apathy.

c. Cognitive impairment.

d. Sleep.

e. Autonomic dysfunction.

f. Sensory symptoms.

3. The different forms of Parkinson's disease: relevance for prognosis.

4. The differential diagnosis of Parkinson's disease.

5. Treatment-related symptoms.

a. Motor complications.

b. Non-motor complications.

2 Treatment of Parkinson's disease (Anthony Schapira, Andreas Hartmann, Yves Agid).

I. Antiparkinsonian agents.

1. Levodopa.

2. COMT inhibitors.

3. Dopamine agonists.

4. Monoamine oxidase B inhibitors.

5. Other drugs.

II. Medical management.

1. Initiation of treatment.

2. Maintenance of treatment (Fig. 2.7).

3. Motor complications.

4. Management of non-motor complications.

III. Non-medical management.

1. Surgery.

2. Destructive lesions.

3. Cell therapy.

4. Growth factors.

IV. Neuroprotection.

1. MAO-B inhibitors.

2. Dopamine agonists.

3. Coenzyme Q.

4. Creatine.

5. Antiapoptotic drugs.

V. Conclusion.

3 Case studies.

Case studies-diagnostic index.

Index.

Additional information

GOR005779048
9781405196017
1405196017
Parkinsonian Disorders in Clinical Practice by Anthony Schapira
Anthony Schapira
Used - Very Good
Paperback
John Wiley and Sons Ltd
20090508
208
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a used book - there is no escaping the fact it has been read by someone else and it will show signs of wear and previous use. Overall we expect it to be in very good condition, but if you are not entirely satisfied please get in touch with us

Customer Reviews - Parkinsonian Disorders in Clinical Practice